1.Dixon, RE. Costs of nosocomial infections and benefits of infection control programs. In: Wenzel, RP, ed. Prevention and Control of Nosocomial Infections, 1st ed. Baltimore: Williams & Wilkins; 1987:19–25.
2.Jarvis, WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost and prevention. Infect Control Hosp Epidemiol 1996;17:552–557.
3.Pittet, D. Nosocomial bloodstream infections. In: Wenzel, RP, ed. Prevention and Control of Nosocomial Infections, 3rd ed. Baltimore, MD: Williams & Wilkins; 1997:512–555.
4.Smith, SD, Doebbeling, BD. Costs of nosocomial infections. Curr Opin Infect Dis 1996;9:286–290.
5.Wenzel, RP. The economics of nosocomial infections. J Hosp Infect 1995;31:79–87.
6.Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987;25:481–488.
7.DiGiovine, B, Chenoweth, C, Watts, C, Higgins, M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976–981.
8.Landry, SL, Kaiser, DL, Wenzel, RP. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989;17:323–329.
9.Martin, MA, Pfaller, MA, Wenzel, RP. Coagulase-negative staphylococcal bacteremia: mortality and hospital stay. Ann Intern Med 1989;110:9–16.
10.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994;271:1598–1601.
11.Soufir, L, Timsit, JF, Mahe, C, Carlet, J, Regnier, B, Chevret, S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396–401.
12.Spengler, RF, Greenough, WB III. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:2455–2458.
13.Wey, SB, Motomi, M, Pfaller, MA, Woolson, RF, Wenzel, RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645.
14.Haley, RW, Schaberg, DR, Von Allmen, SD, McGowan, JE Jr. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980;141:248–257.
15.Leroyer, A, Bedu, A, Lombrail, P, et al. Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit. J Hosp Infect 1997;35:37–45.
16.Wakefield, DS, Pfaller, MA, Ludke, RL, Wenzel, RP. Methods for estimating days of hospitalization due to nosocomial infections. Med Care 1992;30:373–376.
17.American College Chest Physician/Society Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–874.
18.Crowe, MJ, Cooke, EM. Review of case definitions for nosocomial infection: towards a consensus. J Hosp Infect 1998;39:3–11.
19.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.
20.Young, L. Sepsis syndrome. In: Mandell, GL, Bennett, JE, Dolin, R, eds. Principles and Practice of Infectious Disease. New York: Churchill Livingstone; 1995:690–705.
21.Pearson, ML. Guideline for prevention of intravascular device-related infections. Am J Infect Control 1996;24:262–277.
22.Haug, JB, Harthug, S, Kalager, T, Digranes, A, Solberg, CO. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features and outcome. Clin Infect Dis 1994;19:246–256.
23.McGowan, JE, Barnes, MW, Finland, M. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis 1975;132:316–335.
24.Weinstein, MP, Murphy, JR, Reller, LB, Lichtenstein, KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults: clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54–70.
25.Pittet, D, Wenzel, RP. Nosocomial bloodstream infections. Arch Intern Med 1995;155:1177–1184.
26.Spencer, RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996;15:281–285.
27.Haley, RW, Culver, DH, White, JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182–205.